Mechanisms of Severe Acute Influenza Consortium (MOSAIC)
NCT00965354 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 131
Last updated 2024-09-19
Summary
The ultimate goal of this collaborative, intensive study is to discover new and effective treatments and to develop better vaccines that can be used in future outbreaks of Influenza A. By integrating the information that we will gather, we will create a unique overview of how influenza causes illness and what might be done to improve patient management.
Conditions
Sponsors & Collaborators
-
Wellcome Trust
collaborator OTHER - collaborator OTHER_GOV
-
Imperial College London
lead OTHER
Principal Investigators
-
Peter JM Openshaw · Imperial College London
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-12-31
- Primary Completion
- 2011-02-28
- Completion
- 2011-02-28
Countries
- United Kingdom
Study Locations
More Related Trials
-
First-in-Human Clinical Trial of a Mosaic Quadrivalent Influenza Vaccine Compared With a Licensed Inactivated Seasonal QIV in Healthy Adults
NCT04896086 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in Households
NCT03969212 ·Status: COMPLETED ·Phase: PHASE3
-
Mucosal and Systemic Immune Responses Induced by an Intranasal Influenza Live Attenuated Vaccine
NCT07232745 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Characterization of Influenza-like Illness in Mexico
NCT01418287 ·Status: COMPLETED
-
A Retrospective, Observational Registry of Participants With Avian Influenza Infection
NCT02743676 ·Status: COMPLETED
-
A Study to Evaluate the Safety, Tolerability and Immunogenicity of a Universal Influenza A Vaccine
NCT01265914 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine
NCT05027932 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study to Assess the Safety of a New Influenza Vaccine
NCT01104493 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge
NCT02071329 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza
NCT03682120 ·Status: COMPLETED ·Phase: PHASE2
-
Virus Shedding and Environmental Deposition of a Novel Influenza Virus
NCT01046734 ·Status: COMPLETED
-
Further Investigation of an Intramuscular Influenza Vaccine (Multimeric-001)
NCT01146119 ·Status: COMPLETED ·Phase: PHASE2
-
The Human Mucosal Immune Responses to Influenza Virus (SLVP026)
NCT03023553 ·Status: COMPLETED ·Phase: PHASE4
-
Studying Cell Immune Responses to a Live Flu Vaccine in Healthy Adults
NCT01730144 ·Status: COMPLETED
-
Immunogenicity Study of the Influenza Vaccine in Adults
NCT00258934 ·Status: COMPLETED ·Phase: PHASE2
-
Characterizing Late-season Influenza Vaccine Responses to Compare the 2023 and 2024 Vaccine Formulations
NCT06567860 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults
NCT00989287 ·Status: COMPLETED ·Phase: PHASE3
-
Influenza in People With Normal and Weakened Immune Systems
NCT00533182 ·Status: COMPLETED
-
Revealing Protective Immunity to Influenza Using Systems Immunology
NCT06501963 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Metabolic Syndrome on Flu Vaccine Efficacy
NCT02653495 ·Status: TERMINATED ·Phase: NA
-
Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults
NCT04782323 ·Status: COMPLETED ·Phase: PHASE2
-
Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)
NCT04664075 ·Status: TERMINATED
-
Acute Respiratory Infection Consortium
NCT01021098 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza
NCT05160636 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluating Modes of Influenza Transmission
NCT01710111 ·Status: COMPLETED ·Phase: NA